Upadacitinib for prurigo nodularis
Clara Muntaner-Virgili, Carlos Moreno-Vilchez, Clara Torrecilla-Vall-Llossera, Ignasi Figueras‐Nart
Abstract
Prurigo nodularis (PN) is a barely-known disease that causes considerable impairment of quality of life for which very scarce treatment alternatives are available.1 Recently, biological drugs and small molecules have been used as off-label treatments. In this article, we report the case of PN treated with upadacitinib with a good response.
Topics & Concepts
Prurigo nodularisMedicineDermatologyPrurigoDermatologic agentsBiologyMicrobiologyAntibioticsDermatology and Skin DiseasesUrticaria and Related ConditionsMedicine and Dermatology Studies History